# PRESat

> pharmaSat Risk Evaluation Satellite

**Wikidata**: [Q7120294](https://www.wikidata.org/wiki/Q7120294)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/PRESat)  
**Source**: https://4ort.xyz/entity/presat

## Summary
PRESat is a CubeSat designed as a pharmaSat Risk Evaluation Satellite, launched on August 3, 2008, to assess pharmaceutical risks in space environments. It represents an early application of miniaturized satellite technology for scientific experimentation.

## Key Facts
- PRESat is an instance of a CubeSat, a class of miniaturized satellites composed of 10cm-sided cubic modules.
- It was launched on August 3, 2008, from the Ronald Reagan Ballistic Missile Defense Test Site.
- The launch vehicle used was a Falcon 1, an orbital rocket developed by SpaceX.
- PRESat is classified as a pharmaSat Risk Evaluation Satellite, indicating its focus on pharmaceutical risk assessment.
- It has 2 sitelinks across its Wikipedia entries in English and Swedish.
- Its Freebase ID is /m/04gjrxt.

## FAQs
### Q: What was the primary purpose of PRESat?  
A: PRESat was designed as a pharmaSat Risk Evaluation Satellite to conduct pharmaceutical risk assessments in space environments, though specific mission outcomes are not detailed in available sources.

### Q: When and where was PRESat launched?  
A: PRESat was launched on August 3, 2008, from the Ronald Reagan Ballistic Missile Defense Test Site.

### Q: What type of rocket carried PRESat into orbit?  
A: PRESat was deployed using a Falcon 1 launch vehicle, an orbital rocket manufactured by SpaceX and a predecessor to the Falcon 9.

### Q: How is PRESat classified in satellite technology?  
A: PRESat is classified as a CubeSat, a standardized format for small satellites built from modular 10cm cubic units.

## Why It Matters
PRESat exemplifies the early adoption of CubeSat technology for specialized scientific missions, particularly in pharmaceutical research. Its launch aboard the Falcon 1—a then-novel commercial rocket—underscores the growing role of private aerospace companies in enabling accessible space experimentation. As one of the first CubeSats focused on pharmaceutical risk evaluation, it contributed to broader efforts to understand how microgravity affects drug stability and efficacy, with implications for future long-duration space missions and potential terrestrial medical applications. Its deployment also highlights the Ronald Reagan Ballistic Missile Defense Test Site’s role in supporting diverse satellite launches.

## Notable For
- Being a CubeSat dedicated to pharmaceutical risk evaluation in space.
- Launching on the Falcon 1, SpaceX’s inaugural orbital-class rocket.
- Operating from the Ronald Reagan Ballistic Missile Defense Test Site, a key U.S. launch facility.
- Representing an early example of CubeSat utilization for life sciences research.

## Body
### Overview
PRESat is a CubeSat classified as a pharmaSat Risk Evaluation Satellite, emphasizing its role in pharmaceutical risk assessment during spaceflight. It adheres to the CubeSat standard, which utilizes modular 10cm cubic units to form compact satellites.

### Launch Details
- **Launch Date**: August 3, 2008  
- **Launch Site**: Ronald Reagan Ballistic Missile Defense Test Site  
- **Launch Vehicle**: Falcon 1, an orbital rocket developed by SpaceX  
- **Significance**: The launch marked a rocket deployment event for PRESat, occurring at the specified site and time.  

### Technical Classification
- **Instance Of**: CubeSat  
- **Alternative Designation**: pharmaSat Risk Evaluation Satellite  
- **Wikipedia Presence**: Available in English and Swedish languages  
- **Digital Identifiers**: Freebase ID /m/04gjrxt  

### Context
PRESat’s launch coincided with the operational phase of the Falcon 1, which preceded SpaceX’s Falcon 9 rocket. Its deployment from the Ronald Reagan Ballistic Missile Defense Test Site reflects the facility’s use for diverse satellite missions beyond ballistic missile defense.

## References

1. Jonathan's Space Report